The sequencing of the human genome and ensuing wave of data generation have brought new light upon the extent and importance of alternative splicing as an RNA regulatory mechanism. Alternative splicing could potentially explain the complexity of protein repertoire during evolution, and defects in the splicing mechanism are responsible for diseases as complex as cancer. Among the challenges that rise in light of these discoveries are cataloguing splice variation in the human and other eukaryotic genomes, and identifying and characterizing the splicing regulatory elements that control their expression. Bioinformatics efforts tackling these two questions are just at the beginning. This article is a survey of these methods.
INTRODUCTION
Alternative splicing of pre-mRNA has captured the attention of the genomics community as an important regulatory mechanism for modulating the gene and protein content in the cell. The discovery that many genes can produce multiple mRNA and protein isoforms, through the regulated selection of different combinations of exons for inclusion into the mRNA, changed irreversibly the outlook of many important genomics problems such as the annotation of genes and their regulation, and inspired hypotheses reaching far into the biomedical and evolutionary biology areas.
The phenomenon of alternative splicing was discovered in concept in the late 1970s [1] , and was then verified experimentally in the 1980s [2] , but the real revolution in alternative splicing occurred about the time of the sequencing of the human genome. The availability of large EST and mRNA data sets stimulated large-scale analyses which estimated that as many as 60% of the human genes undergo alternative splicing to create multiple transcript isoforms [3] [4] [5] . High levels of splicing have been estimated in other mammals recently sequenced, such as mouse and rat [6, 7] . Thus, alternative splicing appears to be the rule rather than the exception in gene expression. With the recent slashing of the number of human genes down to 25 000 [8] , scientists have turned to alternative splicing as a mechanism to potentially explain how a large variety of proteins can be achieved with a relatively small number of genes [9] , and ultimately to explain the paradox between gene content and the complexity of organisms. On a more immediate timescale, errors in the splicing mechanism and its regulation have been investigated as triggers in a number of diseases, including cancers [10] [11] [12] , and such studies may lead to new tools for diagnostics and treatment [13] [14] [15] .
Alternative splicing is the process through which different combinations of exons within a gene are spliced from the RNA precursor to be included in the mature mRNA depending upon the tissue, developmental stage and disease versus normal conditions of the cell. The resulting proteins may exhibit different and sometimes antagonistic functional and structural properties [13, 16] , and may inhabit the same cell with the resulting phenotype being the balance between their expression levels [17] . From a gene structure standpoint, alternative splicing at internal exons manifests itself in four types 
f), but in general are harder to identify and characterize due to noisy data and the intrinsic difficulty in identifying the gene boundaries. Consequently, they have not been reflected with the same prevalence in bioinformatics methods and literature.
The two most important reverberations of alternative splicing in bioinformatics and computational biology are in the areas of gene annotation and splicing regulation [18] . Traditionally, gene discovery was accomplished with a combination of ab initio and comparative methods designed to identify linear exon-intron models of genes along a genomic sequence [19] . Following the sequencing of the human genome, large-scale annotation projects at the major genomics centers (Ensembl [20] , UCSC Genome Browser database [21] , Celera Genome Browser and Otto annotation system [22] ) typically employed a variety of prediction methods to produce 'evidence' for the gene, and used a 'combiner' algorithm to consolidate the different lines of evidence into a representative gene model. Lastly, alternatively spliced forms were added to the automated annotation by human curators in their effort to improve the quality and completeness of the data set. Such sets were tedious to create and captured only partly the repertoire of splicing variation. More recently, the gene annotation landscape has changed to incorporate alternatively spliced transcripts or alternative splicing events as an integral part of the annotation process. There has recently been a concomitant increase in the number of repositories containing and cataloguing alternative splicing information.
Equally important is the question of what causes and/or controls the variation in splicing. Unlike transcriptional control exercised from the promoter, which modulates exclusively the amount of gene expression, the control of alternative splicing determines the abundance, structure and function of transcripts and encoded proteins from a gene, and can alter such salient properties of proteins as binding affinity, intracellular localization, enzymatic activity, stability and post-translational modifications [23] . Furthermore, exon selection in alternative splicing can be tissue, developmental stage or disease specific [13, 24] , or can change in response to external stimuli such as receptor stimulation, cellular stress or changes in neuronal activity [25] . Thus, the regulation of alternative splicing presents a more versatile and finer granularity control than transcriptional regulation.
Most of the splicing regulation that is not part of the basal spliceosome function is known to be undertaken by families of splicing regulatory proteins. These splicing factors bind to signals in the vicinity of the exon and promote the exon's inclusion or exclusion by activating or inhibiting the function of the splice site. The number of classes and characteristics of these regulatory proteins and their RNA binding sites are relatively little known and are currently under active investigation.
In this article, we present an overview of bioinformatics methods to date to identify, characterize and catalogue alternative splicing and its regulation.
IDENTIFICATION OF SPLICE VARIANTS
While different tissues or cell types in an organism have roughly the same genome, their transcriptomes could be significantly different. The end goal of alternative splicing annotation is to identify and catalogue all mRNA transcripts in the cells of an organism at various stages, together with relevant information about their spatial and temporal expression and function. This is analogous to the gene annotation problem that has been in the cross hairs for the past two decades. Given the incomplete and fragmented nature of the data and the insufficient experimental characterization, this goal is currently difficult to achieve, if not impossible (specific challenges are listed in the forthcoming sections). A variation that is more readily attainable and can be just as powerful for practical purposes, such as designing diagnostic markers that can be tested in vitro via microarray and proteomic experiments [26] or in silico [27] is that of identifying and annotating splice forms, i.e. mutually exclusive splicing patterns inferred from partial cDNA and/or protein sequences, or exon-level alternative splicing events. Of particular interest are exons or combinations of exons that undergo different splicing patterns.
Bioinformatics
Approaches for identifying full-length splice variants or just splice forms typically involve the comparison of two or more expressed DNA or protein sequences of different isoforms to detect differences caused by insertions or deletions of genetic material. Direct comparison between the sequences of different cDNA and protein isoforms (Figure 2a ) reveals the differences between the sequences compared, but does not characterize them in the context of the gene's structure. The observed difference can be an exon, part of an exon, or a set of consecutive exons and exon portions. In contrast, comparisons of exon^intron structures from cDNA-or proteingenomic spliced alignments clearly distinguish among the types of alternative splicing events ( Figure 2b ) and provide an extended genomic context in which the nearby splicing regulatory regions can be explored.
Sequence data
Computational approaches rely on cDNA and protein sequences collected in large repositories in GenBank and around the world. Database for expressed sequence tags (dbEST) [28] contains single-pass EST sequences from direct submissions to GenBank. RefSeq [29] is an NCBI effort to collect, review and curate full-length mRNA sequences from submissions or gene prediction projects. More recently, the Mammalian Gene Collection (MGC) project [30] was started as an NIH initiative to clone and sequence full-length open reading frames (ORFs) for human, mouse and rat genes. Protein sequences can be obtained from databases such as SwissProt, TrEMBL and PIR, currently united into the Universal Protein Knowledgebase UniProt [31] . The quality and characteristics of the data may differ significantly, and thus in judging the potential for identified differences to represent true alternative splicing events considerations about the type, quality and reliability of data are important.
Alignment tools
A number of specialized programs have been developed to align cDNA sequences to genomic sequences allowing for sequencing errors, polymorphisms and introns, such as EST_GENOME [32] , Sim4 [33] , Spidey [34] , and GeneSeqer [35] . These programs were designed specifically to compare a cDNA with the restricted genomic range encompassing the gene. With the availability of whole genome sequences, new generation tools were developed to efficiently map large cDNA data sets to large chromosomal sequences and whole genomes. Examples include Blat [36] , ESTmapper [37] , MGAlignIt [38] , and GMAP [39] . Given a cDNA sequence, each of these programs generates a spliced alignment of the cDNA and the genomic sequence. The alignment clearly marks the locations of exons and introns in the two sequences and gives additional information about the match, such as the predicted strand and alignment quality statistics. Although all of these programs have reached a high level of accuracy, challenges remain in dealing with non-canonical splice junctions, high EST sequencing error rates or specific types of sequencing errors, detecting small exons and/or large introns, and correctly determining the true location of the cDNA on the genome from among multiple paralogous matches.
BIOINFORMATICS METHODS
Since identifying partial splice forms and alternative splicing events via differences between different isoforms is intuitive, subsequently we focus on the more complex task of annotating full-length alternatively spliced transcripts. Such methods include gene indices, which assemble putative splice variants from overlapping EST and mRNA sequences without resorting to a reference genome, and genome-based methods for clustering spliced alignments and inferring gene models.
Gene indices
Gene indices are gene-or transcript-oriented collections of EST and mRNA sequences grouped by sequence similarity. Traditional methods compare all EST and mRNA sequences against each other to identify significant overlaps, then group and Clustering and assembly of EST sequences into transcript-oriented groups and contigs. (e) EST sequences from the 5 0 and 3 0 ends of the gene are compared to identify compatible overlaps and then assembled into consensus sequences (TC1, TC 2) representing putative splice variants. Spliced alignments of cDNAs on the genome (E1^E5) are clustered along the genomic axis and consolidated into splice graphs.Vertices in the splice graph represent exons (a^h), arcs are introns connecting the exons consistently with the cDNA evidence, and a branching in the graph signals an alternative splicing event. Splice variants (V1^V4) are read from the graph as paths from a source vertex (with no 'in' arc) to a sink vertex (with no 'out' arc). In some systems, they are assigned scores based on the strength of the supporting evidence, based on which high-scoring candidates are selected for inclusion into the annotation and/or for validation experiments.
assemble sequences with compatible overlaps into disjoint clusters (Figure 2d ). The term 'gene indices' may be used to refer to the annotated collections of sequences (UniGene [40] ), to the multiple alignments of sequences in the clusters, or to the consensus sequences generated from the multiple alignments (TIGR Gene Indices [41] , GeneNest [42] ).
Constructing gene indices is complicated by a number of factors. Over-clustering may occur when differences between paralogs are interpreted as sequencing errors, forcing paralogs into a same cluster, or when contamination of ESTs with vector or linker sequences or residual polyA tails creates false appearances of overlaps. Other times, insufficient EST sampling may result in underclustering, where several disconnected clusters are produced for a same gene. Furthermore, the process is computationally expensive, as the time required by the pairwise comparisons increases quadratically with the number of sequences in the set. To alleviate these problems, methods were developed to trim the vector and low-quality ends of the EST sequences prior to the comparison, pre-cluster the sequences by aligning EST sequences against the known primary mRNA form (seeded clustering), and to a priori cluster almost identical or contained sequences to reduce the complexity of the clustering [43] .
Genome-based clustering and assembly
In the genome-based approach, the spliced alignments of cDNA and protein sequences are clustered at loci along the genomic sequence. To distinguish among possibly different genes sharing the same genomic locus, including overlapping genes and sense-antisense transcripts [44] , clustering is often refined to group alignments separately on each strand of the genomic sequence, and requires that the sequences share common splice junctions in addition to overlapping exons. One recent innovation in alternative splicing annotation has been the concept of a splice graph, as a model for concisely capturing splice variations within a gene. The splice graph represents a gene as a directed acyclic graph in which exons are represented as vertices, introns are the arcs connecting the exons, and splice variants are the paths obtained by traversing the graph from a source vertex (with no incoming arcs) to a sink vertex (with no outgoing arcs). With this set of rules, cDNA and protein spliced alignments at a genomic locus can be consolidated into a spliced graph ( Figure 2e ) and candidate full-length splice variants can be enumerated from the graph in a combinatorial fashion. The combinatorial nature of the splice graph is also, however, the main limitation of the model, since some of the exon combinations it encodes may be artificial constructs without biological relevance. Different methods have been proposed to select or prioritize candidate transcripts in order to differentiate between those most likely to be biologically relevant and those likely to be artifactual. For instance, the annotation intergrated resource AIR annotation pipeline [37] assigns splice variants confidence scores based on a set of four characteristics measuring the strength of the supporting cDNA and protein evidence, such as the quality and length of the supporting alignments, accuracy of splice signals and the level of fragmentation of the evidence. High-scoring candidates are later selected and promoted into the annotation. The ECgene [45] system classifies candidate transcripts into three categories, high-, medium-and lowconfidence, based on the number of cDNA alignments that were stitched together to construct it. Other methods simply defer the task of transcript selection to the users, but provide additional information and visualization to aid in the analysis [46, 47] .
The genome-based approaches solve a number of deficiencies observed with the gene indices. By mapping the ESTs to the genome contamination from foreign matter, such as vector and linker sequences, or from polyA tails are removed. In addition, the sequencing errors that were compounded between the cDNA sequences in the gene indices method are now resolved by aligning the sequence against the genome, used as reference. As a result, fewer sequences are misplaced along the genome, resulting in considerably less clustering of paralogs. However, genome-based clustering has its own set of limitations. Some of the remaining issues that have to be resolved involve the contamination of ESTs with genomic fragments or incompletely spliced forms that could produce over-clustering of neighboring or overlapping genes, errors in the alignment, particularly inaccuracy of splice junctions and missing short exons, and strand prediction. Other limitations of the splice graph model include its inability to fully capture splicing variations where one variant is a 5 0 or 3 0 extension of another, and its sensitivity to alignment errors, as one spurious exon may double the number of candidates.
Identifying splice variation from microarray data
Recently, the Affymetrix chip design using multiple probes per gene has been used to identify splice variations. The Affymetrix GeneChip technology uses 22 probes collected from within the exons or straddling the exon boundaries in the 3 0 UTR of the sampled genes (Figure 2c ). When an exon is alternatively spliced between two microarray experiments, the expression level of its probes in the two arrays will be different and, in at least one of the experiments, significantly dissimilar to those of their neighbors. Thus, statistical tests were developed to determine the significance of these differences and to predict alternative splicing events [48, 49] .
RESOURCES FOR ALTERNATIVE SPLICING
The recent years have witnessed a growth in the number of resources-programs, databases and web servers-for the identification and analysis of alternative splicing, directly reflecting the variety of data generation methods. A summary of these resources is given in Table 1 .
A growing number of databases have emerged that collect instances of alternative splicing events inferred computationally from pairwise comparisons of cDNA and protein sequences (PALSdb [52] , EASED [55] ), their genomic exon-intron structures (ASAP [50] , AltExtron and AltSplice [51] , SpliceInfo [54] ), or GenBank annotations (AsMamDb [53] ). In addition to sequence and splicing-related information, they may contain annotations such as tissue specificity, developmental stage, expression data, exon GC and repeat content, conservation in other species and the biological function where known. In contrast, the AEDB database maintained as part of the alternative splicing database (ASD) [51] contains experimentally identified alternatively spliced exons and splicing regulatory signals extracted from the literature, with links to relevant MEDLINE entries documenting the events.
In addition to databases, several programs and software pipelines for predicting genes and alternatively spliced transcripts based on genomically aligned cDNA and protein sequences have been developed to support genome annotation projects: ClusterMerge [57] produces the Ensembl ESTgenes, AIR [37] was used to annotate the Celera rat genome, and PASA [56] reconstructed transcripts in the TIGR annotation of Arabidopsis thaliana. Outside the spectrum of genome annotation projects, ASG [46] provides internet accessible splice graphs for several eukaryotic genomes and ASmodeler [58] allows users to create their own splice graph annotations via a web interface.
Lastly, the most comprehensive gene index collections to date are the TIGR Gene Indices [41] and the NCBI UniGene collection [40] . 
HURDLES IN ALTERNATIVE SPLICING ANNOTATION
Although tremendous strides were taken in the past few years to identify and catalogue splice variation in the human and other eukaryotic genomes, this chapter of genomics is still very much a draft. Among the factors that continue to confound annotation methods are:
(i) EST quality-contamination of EST sequences with genomic, cross-species and vector sequences, high sequencing error rates, chimeras; (ii) alignment accuracy-ambiguity of predicted strands, alignment errors, particularly at the splice junctions, missing exons; (iii) limitations in models and data-insufficient data, for instance for tissue-specific clustering, EST fragmentation; and (iv) complexity of biological processes-paralogs, trans-splicing, sense-antisense transcripts and overlapping genes.
With its far-reaching implications for biology and medicine, identifying and characterizing alternative splicing variation is becoming an important part of the effort for detecting and cataloguing the genes. Thus, developing a comprehensive catalogue of splicing variation will require mobilization to produce fast and accurate tools for automatic annotation, coupled with an assiduous curation effort and high-throughput validation by sequencing, RT-PCR and microarray experiments [59] .
ALTERNATIVE SPLICING REGULATION
An equally intense area of research in alternative splicing revolves about the factors and mechanisms of splicing regulation. Pre-mRNA splicing is a complex cellular process undertaken in the cytoplasm by the spliceosome. The spliceosome assembles onto each intron from a set of five small nuclear ribonucleoproteins (snRNPs U1, U2, U4-U6) and numerous accessory proteins that bind specifically to locations at or within the vicinity of the splice sites, and catalyzes the excision of the intron [60] . While the 5 0 (donor) and 3 0 (acceptor) splice sites have well characterized consensus sequences that are recognized to play a major role in splicing, an increasing body of evidence reveals that previously unknown RNA elements located outside the splice signals, in exons and introns, contribute to the exon's inclusion or exclusion in the mature mRNA, in a network of interactions that appear to be centered on exons, rather than introns. These cis-regulatory elements can promote (splicing enhancers) or repress (splicing silencers) the inclusion of the exon in the mRNA through the activity of the bound regulatory proteins, and can be located in the exons-exonic splicing enhancers (ESEs) and silencers (ESS), or introns-intronic splicing enhancers (ISE) and silencers (ISS). They can act from both within the proximity of the exon, or from 300-1000 bp away. It is becoming increasingly evident that many exons, constitutive or alternative, and their surrounding introns harbor both silencing and enhancing elements, and that the exon's inclusion/exclusion is the result of competition between the two effects [61] .
Mechanisms of splicing activation
Exonic enhancers are the binding sites of splicing activator proteins, the most studied activators being the SR (Ser/Arg) factors. The SR proteins are characterized by the presence of 1-2 RNA recognition motifs (RRM), and a C-terminal RS-domain enriched in Arg/Ser dipeptides. The primary mechanism by which they promote splicing is by attaching to enhancer elements within the exon or in the polypyrimidine tract via their RRM domain and recruiting the U2AF factor with their RS domain. An RS-domain independent mechanism has also been hypothesized, in which the splicing factor binds to an ESE to antagonize the effect of a neighboring silencer [62] (Figure 3a,b) . Exonic splicing enhancer motifs have been characterized through a variety of bioinformatics methods and through functional experiments. Their mechanism, diversity and action were reviewed in [63] .
Mechanisms of splicing repression
Splicing silencers are thought to be binding sites of splicing repressor proteins. Splicing repression is effected largely through the activity of the hnRNP protein families. Of these, hnRNP I, also known as PTB [64] , members of the hnRNP A/B families, and the neuron-specific NOVA-1 inhibitor [65] are among the best characterized. Several mechanisms have been proposed for hnRNP-mediated silencing (Figure 3c-e) : by interfering with the spliceosome assembly through cooperative binding of several inhibitory elements, by blocking neighboring ESEs, or by binding to duplicate intronic sequences on both sides of the exon to form a loop that renders the exon inaccessible to the spliceosome. Experimentally identified or validated ISS sequences were reviewed in [66] .
BIOINFORMATICS METHODS FOR IDENTIFYING SPLICING REGULATORY ELEMENTS
Methods for identifying and characterizing splicing regulatory elements are still in their infancy, varying from experimental to computational and from focused to large-scale, and can be centered on the splicing factors (proteins) or their binding sites.
Emphasizing that all types of approaches have produced valuable results, we hereto focus on computational methods. While there are many similarities with the detection of transcriptional regulatory sites, the specific challenges associated with identifying splicing regulatory sites arise from the fact that few proteins have been identified, and that the full extent of splicing regulatory factors, including the number of proteins and the prevalence of their binding sites on the pre-RNA sequence, cannot be estimated yet.
Consensus sequences
Most early work on splicing enhancers targeted purine-rich exonic elements that were thought to be binding sites of SR proteins (Table 2 ) and produced a number of site consensus sequences [62] . A consensus sequence uses IUPAC codes to specify what symbols are allowed at every position in the motif's sequence, but cannot quantify the preference for certain symbols at a given motif position. The purine-rich model for regulatory sequences was put to rest when ESE sequences in IgM and in the avian sarcoma pre-mRNA were found to retain their effect in vitro even after their purine-rich stretches were eliminated [67, 68] .
Position weight matrices
Position weight matrices (PWMs) are a more suitable model for specifying the variability of symbols in a motif sequence. The PWMs are matrices of scores constructed from the nucleotide frequencies at each position within the motif, typically derived from a collection of experimentally identified sites ( Figure 4) . A PWM specifies a score for each nucleotide at every motif position. The score of a candidate oligonucleotide sequence is then computed as the sum of the individual nucleotide score contributions, and used as an indicator for the reliability of the match: the higher the score, the stronger and more reliable the match. The PWMs for four splicing activator factors, SF2/ASF, SC35, SRp40 and SRp55, were constructed from alignments of binding sites identified with functional in vivo and in vitro systematic evolution of ligands by exponential (SELEX) enrichment experiments using a minigene construct to test the effects of ESEs on splicing [69] . These are the only experimentally derived PWMs of splicing factors to date.
Statistical over-representation of k-mers
Statistical methods, emblematic for post-genome large-scale genomics, aim at identifying sequence elements that are enriched in one class of contexts, defining the biological setting of the element sought, compared with another, defining the background or null setting. Typically, the candidate sequence elements are simple oligonucleotides of length k (k-mers), thought to form the core of splicing regulatory motifs. The methods start with the set of all k-mers, for a value of k selected based on statistical or empirical considerations, and assign them scores that measure the difference between the oligonucleotide frequencies in the two types of contexts. Thus, the first step of such methods consists of identifying a number of attributes that biologically characterize the elements, and the two sets of contexts, 'functional' versus 'null', for each attribute. Each candidate k-mer is then assigned a value for each attribute that statistically characterizes its relative positioning between the two contexts. Lastly, a set of candidate k-mers that show statistically significant differences between the two contexts for each of the attributes is selected for further analysis or for validation in vivo or in vitro.
Several variations of this model have been used under different biological assumptions, or attributes. Fairbrother et al. [71] started from the following assumptions about ESE elements: (i) ESE motifs are more likely to occur in exons than in introns; and (ii) ESE motifs are more likely to occur in weak exons (with non-consensus splice sites) than strong exons (with consensus splice sites). For k ¼ 6, the score function for each of the 4096 6-mers was calculated as the difference between the frequency of the k-mer in exons versus introns, and in weak versus strong exons, scaled by the standard deviation of the sample. Candidates that showed significant enrichment in both tests, corresponding to a scaled difference value larger than 2.5 (or equivalently, with scaled differences >2.5 standard deviations) were selected. These hexamer sequences were then clustered by sequence similarity and aligned to form PWMs for ESE motifs. A similar approach led to the computational rediscovery of the UGCAUG hexanucleotide motif in introns proximal to brain-tissue specific alternative exons, by comparing the frequency of the hexamer in introns downstream of constitutive versus alternatively spliced exons [72] . The motif had been previously experimentally identified as part of a splicing enhancer for exon N1 in the c-src gene [73] . In another study, Zhang and Chasin [74] focused on constitutive splicing and searched for 8-mers over-represented in internal noncoding exons, thought to contain signals 
Motif discovery
Motif discovery methods commonly used in identifying transcription factor binding motifs in unaligned sequences, such as MEME [75] and Gibbs sampling [76] , can also be employed to identify splicing regulatory signals. Although they achieved some success in identifying two regulatory motifs in introns surrounding 54 alternatively spliced exons [77] , it is hard to estimate what their predictive power will be in a large set of diverse sequences, harboring a potentially wide variety of regulatory signals with low sequence specificity. For best results, pre-selecting and curating the data, for instance by selecting tissue-specific events, or validating the results with an independent method, such as comparative studies of alternatively spliced exons in the human and mouse species [77] , is essential.
Comparative studies
Conserved regions in alignments of orthologous introns of human and mouse, or similarly related species, provide good candidates for functional sequences. Surprisingly, in the context of alternative splicing, comparative methods have focused less on predicting specific splicing regulatory signals and more on characterizing the large-scale patterns of sequence conservation [78, 47] , or on validating motifs identified by other methods [77] . For instance, intronic sequences flanking alternatively spliced exons compared to constitutive exons were found to be more strongly conserved between human and mouse, thus suggesting that their splicing mechanisms may be different from those of constitutively spliced exons [78] .
Identification of regulatory signals within coding sequences of exons by sequence comparison is further complicated by the fact that additional selective pressure is imposed on the coding sequence by the necessity to preserve the protein. Several studies , derived from the site nucleotide counts (N) and frequencies (f ) with a log-odds formula [70] .The score for a candidate nucleotide sequence is the sum of individual nucleotide scores at the corresponding motif positions: the higher the score, the better the match and the more likely to be real.
showed that purifying selective pressure may act against silent mutations in certain regions in the coding sequence [79] , and that the phenomenon is more pronounced in alternatively spliced exons [80] . There are also indications that exonic portions of splice sites may undergo positive selection to stabilize during the evolution of introns after insertion [81] . These findings may herald new methods, based on sequence evolutionary models and tools and taking advantage of the large volumes of multi-species data becoming available. Already, Blanchette [82] used phylogenetic methods to distinguish between conservation due to amino acid constraints and conservation due to regulatory factors in predicting splicing regulatory signals in coding sequences.
RESOURCES FOR ALTERNATIVE SPLICING REGULATION
The repertoire of resources to aid in annotating splicing regulatory regions reflects the early state of bioinformatics and experimental studies in this area. A web-based tool, called ESEfinder, was implemented to allow users to search their sequences for matches to the binding motifs of four splicing activators identified by SELEX experiments, SF2/ ASF, SC35, SRp40, SRp55 (http://rulai.cshl.edu/ tools/ESE/) [83] . Another web-based tool, RESCUE-ESE [84] , searches user-input sequences for the presence of specific 6-mer motifs previously identified as potential cores of splicing regulatory motifs by statistical over-representation methods (http://genes.mit.edu/burgelab/rescue-ese/). The SpliceInfo [54] alternative splicing environment (http://spliceinfo.mbc.nctu.edu.tw/) provides tools for the discovery of sequence or structural motifs (Mfold [85] , Gibbs sampling [76] , MEME [75] ) in sequences of annotated exons and introns, while the AEDB [51] database (http://www.ebi.ac.uk/asd/ aedb/) collects experimentally identified splicing regulatory sites and sequences from the literature. Lastly, more general sequence alignment and visualization tools such as PipMaker [86] (http:// pipmaker.bx.psu.edu/pipmaker/) and Vista [87] (http://genome.lbl.gov/vista/mvista/submit.shtml) can aid in the discovery of intronic regulatory signals.
CONCLUSIONS
Alternative splicing is without doubt one of the most important gene regulatory mechanisms, and one that has reemerged as a central concept in the postgenome sequencing era. Determining the extent and importance of alternative splicing required the confluence of critical advances in data acquisition, improved understanding of biological processes and the development of fast and accurate computational analysis tools. While tremendous progress has been made in annotating alternative splicing variations and exploratory steps were taken into the regulation of alternative splicing, there is a long path to fully understanding how it manifests itself in the cell and what are the determining factors to be able to use and interpret this information in disease diagnostics and treatment. In creating an alternative splicing compendium, comparative and functional genomics efforts must address immediate challenges such as improving the accuracy of annotations by differentiating informative events from experimental or computational artifacts and by evaluating the accuracy of existing methods, as well as medium-to long-term goals, including the systematic generation of EST and mRNA sequences from a variety of tissues and under various cell conditions, the development of new methods for the prediction and analysis of splicing regulatory elements and mechanisms, and breakthroughs in high-throughput technologies for in vitro and in vivo validation and functional characterizations. These are the first steps toward the genetic medicine of the future.
